Why first-line choices matter in metastatic TNBC: many miss second-line care, and new antibody-drug conjugates boost survival over chemo.
Theresa L. Harrington Stukus, ANP-BC
Advertisement
Articles by Theresa L. Harrington Stukus, ANP-BC
Oncology NPs discuss new frontline options for metastatic triple-negative breast cancer, using cases to guide therapy choice and manage toxicities.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Oncology Nursing News
1
Ovarian Reserve Markers Predict Chemotherapy Benefit in Breast Cancer
2
Myeloma Care: Quad Therapies, Bispecifics, and the Role of Oncology Nurses
3
Tudriqev Melanoma Approval: Essential Oncolytic Guide for Oncology Nurses
4
Tudriqev Approval: Essential Oncology Nursing Insights
5